Tech Company Financing Transactions

Axial Biotherapeutics Funding Round

OneVentures, Autism Impact Fund and Corundum Systems Biology participated in a $37.3 million Series C funding round for Axial Biotherapeutics. The round was announced on 10/14/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

400 Tradecenter Dr. 6990
Woburn, MA 01801
USA

Phone

(781) 701-8484

Website

www.axialtx.com

Email Address

[email protected]

Overview

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stewart Campbell

        

Chief Financial Officer

Jeffrey Young

        

Vice President

Federico Bolognani

        

VP - Finance

Maura Moroni

        

VP - Operations

Chris Meyer

        

Browse more venture capital transactions:

Prev: 10/14/2021: TripActions venture capital transaction
Next: 10/14/2021: FitOn venture capital transaction

Share this article

News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary